Loading...
XHKG
2327
Market cap111mUSD
Oct 09, Last price  
0.21HKD
1D
-3.70%
1Q
-16.80%
Jan 2017
-45.26%
IPO
-51.69%
Name

Meilleure Health International Industry Group Ltd

Chart & performance

D1W1MN
XHKG:2327 chart
P/E
22.21
P/S
23.10
EPS
0.01
Div yield, %
2.55%
Shrs. gr., 5y
-0.99%
Rev. gr., 5y
-32.73%
Revenues
37m
-27.94%
206,572,000317,429,000472,089,000636,482,000175,309,000203,787,00035,648,00035,079,0009,336,00057,003,00063,918,00068,705,000230,542,000234,779,000265,135,000253,031,000119,894,000129,304,00050,676,00036,518,000
Net income
38m
+16.94%
27,055,00058,105,00051,522,00064,582,000255,663,00070,620,00041,754,00089,219,0001,981,0007,734,00034,464,00080,066,00080,537,000-23,010,00083,439,00060,323,00017,822,00040,830,00032,480,00037,983,000
CFO
-50m
L
29,730,00044,457,00028,825,00050,731,000295,114,000119,776,00051,094,00071,595,0003,344,00016,000-232,997,000-67,981,00017,907,00025,409,00070,805,000-83,270,00043,151,000-136,491,000185,996,000-50,019,000
Dividend
Sep 09, 20260.0015 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Meilleure Health International Industry Group Limited functions as an investment holding company, overseeing a broad spectrum of ventures in Hong Kong, the People's Republic of China, and other international markets. Its diverse operations include industrial hemp, healthcare-related services, trading, various agency services, and both property investment/leasing and development. The company actively engages in the commerce of construction supplies, the creation and sale of residential real estate, property asset management, and the distribution of health-related goods. Furthermore, it provides real estate brokerage, services focused on the application of cannabidiol (CBD) derivatives, and comprehensive health management offerings, such as anti-aging treatments, aesthetic medicine, and general wellness consulting. It also acts as an agent for healthcare product sales. Formerly known as U-Home Group Holdings Limited, the company rebranded to Meilleure Health International Industry Group Limited in March 2017. Its primary corporate office is located in Admiralty, Hong Kong.

Key people

Wentao Zeng
Executive Co-Chairman of the Board · since 2019
Xuzhou Zhou
Executive Co-Chairman of the Board · since 2019
Wen Chuan Zhou
Chief Executive Officer, Executive Director · since 2025
Chief Financial Officer, Company Secretary · since 2019
Non-Executive Director · since 2015
Chi Wai Chau
Independent Non-Executive Director · since 2013
Non-Executive Independent Director · since 2024
Peng Wu
Non-Executive Independent Director · since 2019
IPO date
Oct 14, 2003
Employees
66
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT